Form 8-K - Current report:
SEC Accession No. 0001493152-21-032474
Filing Date
2021-12-27
Accepted
2021-12-27 07:05:12
Documents
15
Period of Report
2021-12-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41597
2 ex10-1.htm EX-10.1 179707
3 ex99-1.htm EX-99.1 11109
4 ex99-1_001.jpg GRAPHIC 6118
  Complete submission text file 0001493152-21-032474.txt   444608

Data Files

Seq Description Document Type Size
5 XBRL LABEL FILE mbot-20211222_lab.xml EX-101.LAB 34476
6 XBRL PRESENTATION FILE mbot-20211222_pre.xml EX-101.PRE 22609
7 XBRL SCHEMA FILE mbot-20211222.xsd EX-101.SCH 3054
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3602
Mailing Address 25 RECREATION PARK DR SUITE 108 HINGHAM MA 02043
Business Address 25 RECREATION PARK DR SUITE 108 HINGHAM MA 02043 908-938-5561
Microbot Medical Inc. (Filer) CIK: 0000883975 (see all company filings)

EIN.: 943078125 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19871 | Film No.: 211518904
SIC: 2836 Biological Products, (No Diagnostic Substances)